Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai

Bin Luo, Jianjun Sun, Rentian Cai, Yinzhong Shen, Li Liu, Jiangrong Wang, Renfang Zhang, Jiayin Shen, Hongzhou Lu, Bin Luo, Jianjun Sun, Rentian Cai, Yinzhong Shen, Li Liu, Jiangrong Wang, Renfang Zhang, Jiayin Shen, Hongzhou Lu

Abstract

To investigate the frequency and the spectrum of major opportunistic infections (OIs), evaluate the major clinical factors associated with each specific OI, and identify the risk factors for in-hospital death among HIV patients in East China.A retrospective cohort study was made including all the HIV-infected patients who were admitted for the first time to the Shanghai Public Health Clinical Center during June 1, 2013 to June 1, 2015. The demographic and clinical data were collected. Comparison of continuous variables was analyzed by one-way ANOVA and rank sum test. Person χ test and Fisher exact test were applied to analyze the categorical variables. A Cox proportional hazards regression model was used to determine the risk for the occurrence of in-hospital death.In total, 920 patients were enrolled with age of 41.59 ± 13.36 years and 91% male. Median CD4 was 34 (IQR, 13-94) cells/μL. Among these patients, 94.7% acquired OIs while the rest developed malignancies. Pneumocystis pneumonia and bacterial coinfection (42.1%) was found to be the most common OIs, followed by tuberculosis (31.4%), CMV (20.9%), Cryptococcosis (9.0%), and MAC infection (5.2%). Of the above 5 major OIs, CMV-infected patients had the lowest median CD4 cell count 22.50 (IQR, 7.50-82.00) while the patients with tuberculosis infection had the highest count 61.00 (IQR, 27.00-176.00). In-hospital death rate was 4.2 per 100 person-years among these patients. Of note, admitted patients with 2 types of OIs (2.20, 95% CI 1.39-3.48) and those patients who were 40-year old or older (1.75, 95% CI 1.10-2.78) had a higher risk of such death.Pneumocystis pneumonia and tuberculosis were still the leading causes for the admission of HIV-infected patients in East China, and these patients tended to have very low CD4 cell counts. It is believed that expanding the HIV screening test and pushing the infected ones get ART earlier is required for generating a more successful HIV management strategy.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flow diagram of the study.
FIGURE 2
FIGURE 2
Incidence of in-hospital death caused by specific type of opportunistic infections.

References

    1. National Health and Family Planning Commission. China Global AIDS Response Progress Report, 2015. Available at: . Accessed December 9, 2015.
    1. Croda J, Croda MG, Neves A, et al. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009; 37:1605–1611.
    1. Huang L, Quartin A, Jones D, et al. Intensive care of patients with HIV infection. N Engl J Med 2006; 355:173–181.
    1. Casalino E, Wolff M, Ravaud P, et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18:1429–1433.
    1. Zhang F, Haberer JE, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21:S143–148.
    1. Zheng H, Wang L, Huang P, et al. Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study. BMC Public Health 2014; 14:831.
    1. Okome-Nkoumou M, Guiyedi V, Ondounda M, et al. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study. Am J Trop Med Hyg 2014; 90:211–215.
    1. Fenner L, Reid SE, Fox MP, et al. Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Trop Med Int Health 2013; 18:194–198.
    1. Saha K, Firdaus R, Santra P, et al. Recent pattern of co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J 2011; 8:116.
    1. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis 2007; 44:599–604.
    1. Shahrin L, Leung DT, Matin N, et al. Characteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: Bangladesh. PLoS One 2014; 9:e113095.
    1. Oh MD, Park SW, Kim HB, et al. Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis 1999; 29:1524–1528.
    1. Katano H, Hishima T, Mochizuki M, et al. The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan. BMC Infect Dis 2014; 14:229.
    1. Xiao J, Gao G, Li Y, et al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PLoS One 2013; 8:e75915.
    1. Siberry GK, Abzug MJ, Nachman S, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J 2013; 32:i–KK4.
    1. Zhu H, Napravnik S, Eron JJ, et al. Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China. J Acquir Immune Defic Syndr 2013; 63:e150–e157.
    1. Ghate M, Deshpande S, Tripathy S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis 2009; 13:e1–e8.
    1. Hajiabdolbaghi M, Jafari S, Mansouri S, et al. Hospitalizations and its related factors in HIV/AIDS patients in Tehran, Iran. Med J Islam Repub Iran 2014; 28:70.
    1. Feldman C, Anderson R. HIV-associated bacterial pneumonia. Clin Chest Med 2013; 34:205–216.
    1. Huang L, Crothers K. HIV-associated opportunistic pneumonias. Respirology 2009; 14:474–485.
    1. Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest 1995; 108:415–418.
    1. Skelly M, Hoffman J, Fabbri M, et al. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 2003; 361:1267–1268.
    1. Damtie D, Yismaw G, Woldeyohannes D, et al. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res Notes 2013; 6:534.
    1. Sun HY, Chen MY, Hsieh SM, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis 2006; 59:311–316.
    1. Mitiku H, Weldegebreal F, Teklemariam Z. Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia. HIV AIDS (Auckl) 2015; 7:137–144.
    1. Barr CE. Oral diseases in HIV-1 infection. Dysphagia 1992; 7:126–137.
    1. Kwamin F, Nartey NO, Codjoe FS, et al. Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana. J Infect Dev Ctries 2013; 7:41–45.
    1. Ravimohan S, Tamuhla N, Steenhoff AP, et al. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. J Infect Dis 2013; 208:1784–1793.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する